Experience of intravitreal injections in a tertiary Hospital in Oman

Experience of intravitreal injections in a tertiary Hospital in Oman

Aim: To find out statistical data regarding intravitreal injections in an outpatient department setup at a tertiary center in Oman. Design: Retrospective chart review. Methods: Data collection of patients who underwent intravitreal injections from November 2009 to May 2013 at Sultan Qaboos Universit...

Full description

Bibliographic Details
Main Author:	Ahmed S Al-Hinai
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2015-01-01
Series:	Oman Journal of Ophthalmology
Subjects:	Antivascular endothelial growth factors choroidal neovascularization diabetic macular edema intravitreal Oman retina retinal vascular occlusion
Online Access:	http://www.ojoonline.org/article.asp?issn=0974-620X;year=2015;volume=8;issue=3;spage=166;epage=170;aulast=Al-Hinai

Similar Items

Intravitreal bevacizumab plus macular laser photocoagulation for treatment of diabetic macular edema
by: Ahmed H Mohamed
Published: (2016-01-01)

Evaluation of early versus late intravitreal bevacizumab injection in the treatment of macular edema secondary to branch retinal vein occlusion
by: Hesham A Enany
Published: (2018-01-01)

Efficacy of Intravitreal Dexamethasone Implant in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion and Resistant to Intravitreal Ranibizumab Injection
by: Ayşe Ergin, et al.
Published: (2022-12-01)

Intravitreal injections: A review of pharmacological agents and techniques
by: Hasanain Shikari, et al.
Published: (2016-01-01)

Retinal pigment epithelium rip following single intravitreal ziv-aflibercept injection
by: Sumit Randhir Singh, et al.
Published: (2018-01-01)

Combination of Ranibizumab and Dexamethasone intravitreal implant for macular edema secondary to retinal vein occlusion
by: Zhu Jing, et al.
Published: (2024-01-01)

Intravitreal injection of anti-vascular endothelial growth factor agents for ocular vascular diseases: Clinical practice guideline
by: Homayoun Nikkhah, et al.
Published: (2018-01-01)

Efficacy of intravitreal Conbercept injection for macular edema secondary to macular branch retinal vein occlusion
by: Ping-Li Zhu, et al.
Published: (2018-01-01)

The Efficacy and Safety of Intravitreal Dexamethasone Implant for the Treatment of Macular Edema Related to Retinal Vein Occlusion: Real-life Data and Prognostic Factors in a Turkish Population
by: Ayşe Yağmur Kanra, et al.
Published: (2017-12-01)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
by: Abraham Hang, et al.
Published: (2023-08-01)

Retinal vein occlusion in Benin City, Nigeria
by: Odarosa M Uhumwangho, et al.
Published: (2016-01-01)

Disease quiescence in endophthalmitis patients treated with anti-VEGF injections for retinal pathologies
by: Brice Nguedia Vofo, et al.
Published: (2024-02-01)

The Efficacy of Simultaneous Injection of Dexamethasone Implant and Ranibizumab Into Vitreous Cavity on Macular Edema Secondary to Central Retinal Vein Occlusion
by: Xing Du, et al.
Published: (2022-03-01)

Report of intravitreal injection of Ranibizumab for macular edema caused by central retinal vein occlusion
by: Jing-Yi Lai, et al.
Published: (2016-04-01)

Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion: a Randomized Clinical Trial
by: Alireza Ramezani, et al.
Published: (2011-01-01)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
by: Singer MA, et al.
Published: (2016-12-01)

INTRAVITREAL IMPLANT OF DEXAMETHASONE IN THE TREATMENT OF RETINAL VEIN OCCLUSION: EFFICACY AND SAFETY
by: A. E. Yavorskiy, et al.
Published: (2015-10-01)

Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration
by: Gopal Lekha, et al.
Published: (2007-01-01)

Incidence of inflammatory reactions after intravitreal injection of a biosimilar of ranibizumab for the treatment of various retinal vascular conditions
by: Vivek Basavprabhu Wani, et al.
Published: (2023-01-01)

“Glaucomatous fields” after monthly intravitreal injections: Normal tension glaucoma or a mimicker?
by: Saumya M. Shah, et al.
Published: (2020-12-01)

Idiopathic Macular Telangiectasia Type 1 treated with Intravitreal Ranibizumab and Laser Photocoagulation
by: Inês Martins de Almeida, et al.
Published: (2015-09-01)

Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study
by: Audrey Giocanti-Aurégan, et al.
Published: (2023-11-01)

Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
by: Yu-Yen Chen, et al.
Published: (2019-12-01)

Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice
by: Andrea Montesel, et al.
Published: (2021-11-01)

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
by: Hamidreza Torabi, et al.
Published: (2018-01-01)

A novel multifunctional, intravitreal injection assistant: evaluation and comparison with conventional technique
by: Dikran G Hovaghimian, et al.
Published: (2016-01-01)

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
by: T. Barth, et al.
Published: (2019-11-01)

Patient-reported outcomes from a phase IV study of aflibercept in patients with refractory retinal vein occlusions
by: Kimberly Spooner, et al.
Published: (2021-01-01)

Antivascular endothelial growth factor in treatment of choroidal osteoma not associated with choroidal neovascular membrane
by: Thomas Cherian, et al.
Published: (2017-01-01)

Intravitreal injection of resveratrol inhibits laser-induced murine choroidal neovascularization
by: Hui-Ming Zhang, et al.
Published: (2020-06-01)

Short-term intraocular pressure changes after aflibercept (Eylea©) intravitreal injections: Which factors should be considered?
by: Renato Correia Barbosa, et al.
Published: (2023-01-01)

Effect of intravitreal aflibercept on corneal endothelial cells: a 6-month follow-up study
by: Muto T, et al.
Published: (2019-02-01)

Efficacy and safety of intravitreal injection of Ranibizumab in the treatment of macular edema secondary to central retinal vein occlusion
by: Gai-Xia Zhai, et al.
Published: (2015-10-01)

Endophthalmitis Postintravitreal Bevacizumab Injections: Incidence, Management, and Visual Outcome in Tertiary Care Center in Pakistan
by: Amna Rizwan, et al.
Published: (2022-01-01)

Intravitreal Triamcinolone Acetonide for Patients with Macular Edema due to Branch Retinal Vein Occlusion
by: Kai-Chun Cheng, et al.
Published: (2006-07-01)

The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs
by: Berker Bakbak, et al.
Published: (2016-01-01)

Recurrence of Macular Hole Retinal Detachment after Intravitreal Ranibizumab Injection for the Treatment of Choroidal Neovascularization from the Remaining Macular Hole Edge
by: Keiko Otsuka, et al.
Published: (2012-12-01)

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population
by: Kumar Atul, et al.
Published: (2007-01-01)

Therapeutic effect of photodynamic therapy and intravitreal injection with ranibizumab for choroidal neovascularization of pathologic myopia
by: Cong Zhang, et al.
Published: (2014-07-01)

Choroidal structural changes determined by the binarization method after intravitreal aflibercept treatment in neovascular age-related macular degeneration
by: Emine Temel, et al.
Published: (2021-08-01)